Comparison of three nasopharyngeal swab types and the impact of physiochemical properties for optimal SARS-CoV-2 detection
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Adequate swab specimen collection, release and detection of nucleic acids by molecular diagnostic assays is largely attributed to the physical and chemical characteristics of different swab types. We investigated properties of three types of commercial nasopharyngeal swabs (nylon flocked: Type 1-Media Merge; Type 2-Kang Jian Medical Apparatus, China and Type 3-Wuxi NEST Biotechnology Co. Ltd, China) used in clinical diagnostics with the aim to establish if different swab designs and configurations had any effect on swab performance. Properties investigated included viral absorption, release, capture, extraction and recovery efficiency from each swab for the detection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). All swab types (n=18) were inoculated with different amounts of SARS-CoV-2 live viral cultures (1:10, 1:100 and 1:1000 copies/ml) and eluted in sterile phosphate buffer saline. RNA was extracted from all swab eluates using a fully automated system (BD MAX™ System) and cycle threshold (Ct) values were compared. RNA stability was also investigated after dry storage of swabs at room temperature for 72 hours. Statistically significant differences (p<0.05) were observed in the absorption and release capabilities between Type 1 and 3 as well as between Type 2 and 3 swabs, however, no significant difference was observed between Type 1 and 2. Ct values and extraction efficiency amounts of SARS-CoV-2 varied amongst the swab types. We conclude that in order to facilitate accurate SARS-CoV-2 diagnosis, assessment of NP swab characteristics is of importance before implementation for specimen collection in the clinical setting.
Article activity feed
-
SciScore for 10.1101/2020.10.21.20206078: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Extracted RNA was quantified using the NanoDrop™ 2000 Spectrophotometer (Thermo Fisher Scientific™ Inc., USA) and the extraction efficiency of each swab was calculated using the following formula: Recovery efficiency was derived from information from Rose et al., (19) and calculated using the following formula:
Thermo Fisher Scientific™suggested: (Thermo Fisher Scientific, RRID:SCR_008452)Statistical analysis: We performed the ANOVA statistical test using Stata/SE 16.0 … SciScore for 10.1101/2020.10.21.20206078: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Extracted RNA was quantified using the NanoDrop™ 2000 Spectrophotometer (Thermo Fisher Scientific™ Inc., USA) and the extraction efficiency of each swab was calculated using the following formula: Recovery efficiency was derived from information from Rose et al., (19) and calculated using the following formula:
Thermo Fisher Scientific™suggested: (Thermo Fisher Scientific, RRID:SCR_008452)Statistical analysis: We performed the ANOVA statistical test using Stata/SE 16.0 (StataCorp LLC, USA) to determine differences among means. StataCorpsuggested: (Stata, RRID:SCR_012763)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:The limitations of this study include the unavailability of clinical specimens for comparison, broader storage times to investigate RNA stability on the swabs as well as inclusion of swabs from well-known manufacturer i.e. Copan and Puritan, which we could not acquire at the time of the study due to high-demand. Future focus would be to validate swabs in clinical settings on a larger population.
Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-